Eli Lilly and Company (LLY.NE)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
40.84-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-3.5%
The outlook
Eli Lilly and Company currently reads as bullish based on above its 50- & 200-day averages, 98% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range98% of the way from its 52-week low to high
Market cap
$1.41T
52-wk high
41.21
52-wk low
22.85
50-day avg
36.30
200-day avg
30.34
Trailing P/E
53.0